Healthy Skepticism Library item: 6150
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Lexchin J.
Appetite stimulant claim deleted from label.
Can Fam Physician 1994 Jan; 40:20,:
Abstract:
Merck is marketing Periactin (cyproheptadine) as an appetite stimulant. All of the studies that Merck uses to justify this indication have serious methodologic flaws.
Keywords:
*letter to the editor/Canada/developed countries/Merck/Periactin/cyproheptadine/quality of information/ appetite stimulants and suppressants/ETHICAL ISSUES IN PROMOTION: COMPANY STANDARDS/EVALUATION OF PROMOTION: GENERAL QUALITY OF INFORMATION/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPED COUNTRIES/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: WEIGHT GAIN AND LOSS
Appetite/drug effects*
Canada
Cyproheptadine/pharmacology*
Drug Industry
Drug Labeling
Humans
Research Design
Stimulation, Chemical
United States
